Shares of Alpharma Inc. jumped Friday, bucking a declining market, as the prospects for approval of its tamperproof morphine drug brightened following a positive Food and Drug Administration panel for a potential rival.
Shares of Harley-Davidson Inc. hit a 10-year low Friday after a Deutsche Bank analyst said the motorcycle maker faces a tough road ahead due to the credit crunch and slumping consumer confidence.
Government health advisers said Friday an experimental morphine pill from Alpharma could discourage some patients from abusing the powerful narcotic but provides only a small advantage over existing drugs.
NEW YORK (AP) - Shares of Alpharma Inc. jumped Friday, bucking a declining market, as the prospects for approval of its tamperproof morphine drug brightened following a positive Food and Drug Administration panel for a potential rival.
GAITHERSBURG, Md. (AP) - Government health advisers said Friday an experimental morphine pill from Alpharma could discourage some patients from abusing the powerful narcotic but provides only a small advantage over existing drugs.
It's 13F filing time again. Institutional money managers who oversee more than $100 million must report their holdings to the SEC each quarter in their 13F report. These reports can be used to analyze the position movements of the best fund managers in the industry. Sometimes they can even be used to figure out the manager’s current strategy, but keep in mind the funds that I am going to review are most likely hedged in some way. Also keep in mind that not every position held is shown in these filings and many of these funds have high turnover; so...
The accompanying table (click to enlarge) presents an updated calendar of 30 decision dates which either have deadlines before year-end or represent delays in previously expected decisions in which the FDA has not issued a new date for a final decision.
The accompanying table (click to enlarge) presents 70 FDA product approval decision dates along with the market caps and one year stock price change for the underlying companies. A note of caution for investors and traders is that the most common outcome from the FDA in the past year has been a delay in decisions due to understaffed conditions at the agency. However, several companies have pending decisions which are likely to occur either before year-end or early next year and will have a major impact on their stock prices.
The ETFI Global AnimalBiz Index includes a total of 35 companies with market caps between $100 million to $10 billion U.S. dollars, with a semi-active rating system which is rebalanced each quarter to choose the top 25 rated companies as active components.
The index excludes all big pharma and diversified healthcare giants which have animal health segments such as Schering-Plough (SGP) [Intervet], Novartis (NVS), Pfizer (PFE), Merck (MRK) + Sanofi-Aventis (SNY) joint venture [Merial], Wyeth (WYE) [Fort Dodge],...
General Electric(GE)– With a little over three weeks to go before September’s options expiration, an investor seems to be less pessimistic over the prospects for shares in consumer-giant, General Electric, than today’s 2.7% share price decline otherwise shows. While we can’t tell if this is the action of one trader, but a look at the footprint left by time and sales data indicates to us that a premium seller is content to wear the risk of a further decline in shares at the conglomerate beneath $25.80. An investor appears...
Last week, much of the news about China’s biomedical industry came from San Diego’s BIO Convention. The “Doing Business Globally Track” of the convention paid attention to the importance that China now has for worldwide biopharma, an industry that is searching for a new business paradigm. Much of the creative energy of the participants was spent discussing the future, which is always an intriguing issue. In the workshop “Opportunities for Collaborations and Investments," the panel compared Asian countries, identifying the problems and opportunities in each...
Alpharma : Comments on Lawsuit filed against Purdue - Leerink Swann.Leerink Swann notes ALO filed a lawsuit late Mon against Purdue in a pre - emptive strike for a declaratory judgment that certain ...
Zacks . com announces the latest list of top performing Zacks # 1 Rank ( " strong buy " ) stocks.The stocks on the prestigious list with the highest returns last week were American Science and ...
( Source : Business Wire ) Zacks . com announces the latest list of top performing Zacks # 1 Rank ( " strong buy " ) stocks.The stocks on the prestigious list with the highest returns last week ...
Zacks . com announces the latest list of top performing Zacks # 1 Rank ( " strong buy " ) stocks.The stocks on the prestigious list with the highest returns last week were American Science and ...
Zacks . com announces the latest list of top performing Zacks # 1 Rank ( ?strong buy ?) stocks.The stocks on the prestigious list with the highest returns last week were American Science and ...
Zacks . com announces the latest list of top performing Zacks # 1 Rank ( " strong buy " ) stocks.The stocks on the prestigious list with the highest returns last week were American Science and ...
CHICAGO - - ( BUSINESS WIRE ) - - Zacks . com announces the latest list of top performing Zacks # 1 Rank ( " strong buy " ) stocks.The stocks on the prestigious list with the highest returns ...
CHICAGO - ( Business Wire ) Zacks . com announces the latest list of top performing Zacks # 1 Rank ( " strong buy " ) stocks.The stocks on the prestigious list with the highest returns last week ...
Alpharma's Embeda ( ALO - 01 ) , a modified - release formulation of morphine coupled with the opioid antagonist naltrexone , is an incremental improvement over existing morphine products because ...
LONDON (MarketWatch) -- UBS downgraded Siemens two notches to sell from buy and also cut Alstom to neutral from buy, saying falling commodity prices and the tough lending environment may lead to a sharp fall in orders from power generation customers. UBS said it thinks a cut in Siemens' 2009 earnings guidance is likely and added 2010 profit expectations look vulnerable unless management significantly steps up restructuring efforts. On Alstom the broker said it still expects solid results in 2009, but has cut its earnings forecast for 2010 by 20% and for 2011 by 46% due to likely...
Drug stocks rallied in early trading Monday, the first session following one of the most devastating weeks ever for investors in the history of Wall Street.
NEW YORK (MarketWatch) -- King Pharmaceuticals Inc. said Monday it would extend its tender offer for all outstanding class A shares of Alpharma Inc. to 5 p.m. ET on Nov. 11. In a news release, the Bristol, Tenn., company said it had already acquired about 18.8 million, or 45%, or Alpharma shares at a tender offer price of $37 each, a 67% premium over the stock's Aug. 4 closing price. The tenderly acquired shares represent a total equity value of about $1.6 billion, the company said. King Pharmaceuticals proposed to buy all of Alpharma class A shares on...
Among the companies whose shares are seeing active trade in Thursday’s session are Huntsman Corp., National City Corp. and International Business Machines.
Stocks 
